Bromhexine Hydrochloride Tablets for the Treatment of Moderate COVID‐19: An Open‐Label Randomized Controlled Pilot Study

This open‐label randomized controlled pilot study aimed to test the study feasibility of bromhexine hydrochloride (BRH) tablets for the treatment of mild or moderate coronavirus disease 2019 (COVID‐19) and to explore its clinical efficacy and safety. Patients with mild or moderate COVID‐19 were rand...

Popoln opis

Shranjeno v:
Bibliografske podrobnosti
izdano v:Clin Transl Sci
Main Authors: Li, Ting, Sun, Laifang, Zhang, Wenwu, Zheng, Chanfan, Jiang, Chenchen, Chen, Mingjing, Chen, Di, Dai, Zhijuan, Bao, Shihui, Shen, Xian
Format: Artigo
Jezik:Inglês
Izdano: John Wiley and Sons Inc. 2020
Teme:
Research
Online dostop:https://ncbi.nlm.nih.gov/pmc/articles/PMC7719397/
https://ncbi.nlm.nih.gov/pubmed/32881359
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/cts.12881
Oznake: Označite
Brez oznak, prvi označite!

Podobne knjige/članki